Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash Flows From Operating Activities:
Net income (loss)	$ (1,001,250)	$ (11,742,932)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Depreciation	0	12,031
Stock-based compensation expense	728,125	7,435,004
Warrants issued for services	0	1,153,643
Stock issued for services	0	350,000
Noncash write-off of related party loan		0
Settlement payment - non-current portion	0	(135,000)
Legal settlement payable in stock	0	(1,597,500)
Legal settlement by stock issuance	0	1,597,500
Changes in operating Assets & Liabilities
Decrease in other receivable	0	531
(Increase)/decrease in prepaid expenses	0	34,133
Increase/(Decrease) in accounts payable and accrued expenses	7,771	319,735
Increase/(Decrease) in accrued payable - related party	100,000	49,096
Increase/(Decrease) in current legal settlement payable	142,974	(25,000)
Net cash provided by (used for) operating activities	(22,380)	(2,548,759)
Cash Flows From Investing Activities:
Purchase of fixed assets	0	(2,078)
Disposal of assets net of depreciation	0	87,748
Deposit paid toward Specialty Pharmacy acquisition	0	50,000
Net cash provided by (used for) investing activities	0	135,670
Cash Flows From Financing Activities:
Proceeds from (paydown of) related party loans	19,758	0
Debt released in acquisition of Canna Colorado	0	1,245
Shares issued to vendor in prior year, paid par this period	0	120
Cash from bank to close overdrawn account	0	4,556
Proceeds from sales of common stock	0	804,550
Net cash provided by financing activities	19,758	810,471
Net Increase (Decrease) In Cash and Cash Equivalents	(2,621)	(1,602,618)
Cash and Cash Equivalents At The Beginning Of The Period	2,621	1,605,239
Cash and Cash Equivalents At The End Of The Period	0	2,621
Schedule of Non-Cash Investing and Financing Activities
Value of stock issued in litigation settlement	0	1,597,500
Supplemental Disclosure
Cash paid for interest	423	2,071
Cash paid for income taxes	$ 0	$ 500